DTC Ads On Television Effectiveness Studied

30 December 1997

Final details are being worked out with an as-yet-unnamed US televisionnetwork for Saatchi & Saatchi Worldwide to study the effectiveness and value of direct-to-consumer prescription drug advertising on television. Nationwide interviews would be done before and after new DTC ads were aired, reports Crain Communications. Moreover, the Food and Drug Administration has asked advertising agencies to collect and submit relevant data in this area.

Interest in TV ads is being stimulated by the ability to reach a large number of people quickly, says Rebecca Sroge, a director at Saatchi unit Kletmer Healthcare. TV ads also reach men, who are hard to get to in print, she added. Other ad agencies said 1998 will see a localization of messages, opening up event sponsorships and promotion through specialty doctors.

Competitive Media Reporting notes that spending for prescription products in measured media rose 50% to $567.2 million for the year through August 1997, with TV spending up a whopping 91% to $84.3 million in the period. There was increased activity in August, when the FDA relaxed rules on DTC TV advertising (Marketletter August 18, 1997).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight